CIPHARMA (Faminter S.A.) was established in March, 2003, in order to take advantage of commercial opportunities offered by the Uruguayan Pharmaceutical Market, for Companies with flexible and modern structures. CIPHARMA was conceived as a company committed to quality in all its areas (products, commercialization, services and information). It is reasonably structured, and it is focused on a flexible operative system so as to seize market opportunities and agreements with other international Companies. Its high-priority objective has always been to grow within a frame of management based on fundamental principles of commercial ethics, in full accordance with the international experience of its founders . CIPHARMA began operations in October 2004 , and over the years has incorporated innovative products for various therapeutic areas . The company has signed exclusive representation contracts with major and leading international laboratories. Our product portfolio covers specialties such as rheumatology , hematology, urology, gynecology, infectious diseases, and Intensive Care Medicine , among others.